Daniele Pastori Selected Research

Sterol Esterase (Hormone-Sensitive Lipase)

1/2020	Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
1/2020	Correction to: Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
12/2019	Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
8/2019	Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
12/2017	Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.
1/2017	Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
7/2015	Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Pastori Research Topics

Disease

53	Atrial Fibrillation 03/2022 - 07/2012
26	Non-alcoholic Fatty Liver Disease 03/2022 - 01/2015
22	Thrombosis (Thrombus) 01/2022 - 07/2012
18	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 08/2014
17	Stroke (Strokes) 03/2021 - 10/2013
16	Hemorrhage 05/2021 - 10/2013
12	Myocardial Infarction 11/2021 - 10/2013
8	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 01/2017
7	Hypertension (High Blood Pressure) 03/2022 - 05/2015
7	Liver Diseases (Liver Disease) 01/2021 - 01/2015
7	Fibrosis (Cirrhosis) 09/2020 - 01/2017
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 05/2015
6	Inflammation (Inflammations) 03/2022 - 01/2014
5	Atherosclerosis 07/2021 - 03/2014
5	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 01/2018
4	Acute Coronary Syndrome 02/2022 - 03/2014
4	Chronic Obstructive Pulmonary Disease (COPD) 08/2021 - 01/2018
4	Heart Failure 07/2021 - 09/2015
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 05/2014
4	Ischemic Stroke 01/2021 - 09/2017
4	Infections 11/2020 - 03/2011
4	Alcoholic Fatty Liver 01/2017 - 01/2015
3	ST Elevation Myocardial Infarction 12/2021 - 01/2021
3	Pneumonia (Pneumonitis) 10/2021 - 12/2016
3	COVID-19 01/2021 - 11/2020
3	Neoplasms (Cancer) 12/2020 - 11/2019
3	Venous Thromboembolism 01/2020 - 03/2016
3	Vascular Diseases (Vascular Disease) 01/2018 - 01/2016
3	Fatty Liver 12/2017 - 10/2015
2	Insulin Resistance 03/2022 - 12/2017
2	Dyslipidemias (Dyslipidemia) 03/2022 - 01/2022
2	Metabolic Diseases (Metabolic Disease) 03/2022 - 05/2018
2	Obesity 01/2021 - 01/2016
2	Hypercholesterolemia 01/2021 - 07/2012
2	Endotoxemia 01/2021 - 10/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2017
2	Diabetes Mellitus 01/2021 - 09/2015
2	Overweight 01/2021 - 12/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2020
2	Embolic Stroke 01/2021 - 07/2020
2	Peripheral Arterial Disease 12/2020 - 05/2020
2	Thrombocytopenia (Thrombopenia) 10/2020 - 11/2019
2	Renal Insufficiency (Renal Failure) 10/2020 - 11/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 03/2011
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 05/2015
2	Cryptogenic Cirrhosis 12/2019 - 01/2017
2	Chronic Renal Insufficiency 11/2019 - 11/2016

Drug/Important Bio-Agent (IBA)

34	AnticoagulantsIBA 07/2021 - 10/2013
23	Vitamin K FDA Link 05/2021 - 08/2015
13	omega-Chloroacetophenone (Mace)IBA 03/2021 - 12/2015
11	AntioxidantsIBA 03/2022 - 08/2014
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 07/2012
7	Antiphospholipid AntibodiesIBA 07/2021 - 01/2019
7	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 10/2014
7	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2020 - 07/2015
6	fibrin fragment D (D-dimer)IBA 02/2022 - 01/2018
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 11/2016
6	LipopolysaccharidesIBA 01/2021 - 06/2017
5	CholesterolIBA 12/2020 - 07/2012
5	EnzymesIBA 01/2020 - 03/2011
4	Transaminases (Aminotransferases)IBA 01/2022 - 03/2011
4	C-Reactive ProteinIBA 11/2021 - 01/2018
4	AntibodiesIBA 10/2021 - 01/2018
4	Anticardiolipin AntibodiesIBA 07/2021 - 05/2019
4	Immunoglobulin G (IgG)IBA 07/2021 - 01/2019
4	IsoprostanesIBA 06/2021 - 03/2015
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2022 - 01/2020
3	LDL CholesterolIBA 07/2021 - 11/2015
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 05/2015
3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2017
3	RivaroxabanIBA 01/2021 - 01/2018
3	Serum AlbuminIBA 01/2021 - 01/2020
3	Oxidants (Oxidizing Agents)IBA 09/2020 - 07/2012
3	Digoxin (Digitek)FDA LinkGeneric 11/2018 - 02/2015
3	Olive OilIBA 11/2018 - 08/2014
3	Vitamin E FDA LinkGeneric 10/2015 - 10/2013
2	HomocysteineIBA 07/2022 - 01/2022
2	Phospholipases (Phospholipase)IBA 03/2022 - 11/2017
2	ElementsIBA 03/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 10/2018
2	Proprotein Convertase 9IBA 01/2022 - 07/2021
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 10/2018
2	Alanine Transaminase (SGPT)IBA 01/2022 - 10/2015
2	oxidized low density lipoproteinIBA 07/2021 - 11/2015
2	TroponinIBA 01/2021 - 08/2020
2	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 01/2017
2	Dabigatran FDA Link 01/2021 - 01/2018
2	AlbuminsIBA 01/2021 - 01/2021
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 05/2015
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 01/2021
2	apixabanIBA 01/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2020 - 08/2011
2	SilymarinIBA 09/2020 - 01/2017
2	SubtilisinIBA 04/2020 - 10/2019
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 04/2020 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018

Therapy/Procedure

15	Therapeutics 03/2021 - 02/2011
9	Mediterranean Diet 03/2022 - 07/2012
6	Percutaneous Coronary Intervention 11/2021 - 08/2011